Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Three-years effectiveness and safety of XEN45 implant: data from the Italian XEN Glaucoma Treatment Registry.

Sara Giammaria; Michele Figus; Gloria Roberti; Chiara Posarelli; Leonardo Mastropasqua; Luca Agnifili; Tommaso Micelli Ferrari; Vincenzo Pace; Matteo Sacchi; Romeo Altafini; Gianluca Scuderi; Andrea Perdicchi; Carmela Carnevale; Antonio Fea; Francesco Oddone

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3502.

ARVO Annual Meeting Abstract June 2024

Proteomic analysis of Peripheral Blood Mononuclear Cells uncovers dysregulation of key pathways in primary open angle glaucoma subjects

Diego Sbardella; Irene Pandino; Sara Giammaria; Gabriele Antonio Zingale; Alessandra Boccaccini; Grazia Raffaella Tundo; Giulia Coco; Gianluca Manni; Michele Figus; Luca Agnifili; Carmela Carnevale; Manuele Michelessi; Gloria Roberti; Francesco Oddone

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3562.

ARVO Imaging in the Eye Conference Abstract June 2023

Automatic Quantification of Major OCT Biomarkers in Diabetic Macular Edema: an AI Validated Approach

Edoardo Midena; Luisa Frizziero; Lisa Toto; Giuseppe Covello; Tommaso Torresin; Giulia Midena; Elisabetta Pilotto; Michele Figus; Cesare Mariotti; Marco Lupidi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0032.

ARVO Annual Meeting Abstract June 2023

OCT Hyperreflective Retinal Foci as Sign of Microglial Activation in Diabetic Retinopathy: an AI Automatic Quantification Approach

Tommaso Torresin; Marco Lupidi; Luisa Frizziero; Lisa Toto; Giuseppe Covello; Giulia Midena; Elisabetta Pilotto; Michele Figus; Cesare Mariotti; Edoardo Midena

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1288.

ARVO Annual Meeting Abstract June 2023

Intraretinal and Subretinal Fluid in Diabetic Macular Edema: an AI Volumetric and Topographic Quantification Approach

Edoardo Midena; Luisa Frizziero; Lisa Toto; Giuseppe Covello; Tommaso Torresin; Giulia Midena; Elisabetta Pilotto; Michele Figus; Cesare Mariotti; Marco Lupidi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2647.

ARVO Annual Meeting Abstract June 2023

The current clinical profile of patients eligible for glaucoma surgery and related type of intervention

Sara Giammaria; Michele Figus; Gianluca Manni; Matteo Sacchi; Gaia Li Calzi; Alessandro Palma; Maria Novella Maglionico; Francesco Oddone

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4279.

ARVO Annual Meeting Abstract July 2019

Color-Code classification versus continuous data by Spectral Domain-Optical Coherence Tomography for detecting glaucoma: Multicenter Italian Glaucoma Imaging Study (MIGIS).

Manuele Michelessi; Ivano Riva; Enrico Martini; Michele Figus; Paolo Frezzotti; Luca Agnifili; Gianluca Manni; Luciano Quaranta; Stefano Miglior; Chiara Posarelli; Stefano Fazio; Francesco Oddone

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5586.

ARVO Annual Meeting Abstract July 2018

Effect of adherence to the Mediterranean diet on diabetic retinopathy and choroidal thickness

Antonio Ferreras; Beatriz Abadia; Pilar Calvo; Francisco Bartol; Guayente Verdes; Carlos Isanta; Michele M Iester; Michele Figus; Ana Belen Pajarin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1913.

ARVO Annual Meeting Abstract June 2017

Diagnostic accuracy of optic disc, macular and retinal nerve fiber layer analysis by means of SD-OCT at different stages of the glaucoma disease: Multicentric Italian Glaucoma Imaging Study (MIGIS).

Manuele Michelessi; Ivano Riva; Stefano Miglior; Luciano Quaranta; Enrico Martini; Paolo Frezzotti; Michele Figus; Gianluca Manni; Luca Agnifili; Chiara Posarelli; Luigi Calandriello; Francesco Oddone

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):699.

ARVO Annual Meeting Abstract June 2017

Artificial tear substitutes and ocular surface in glaucoma patients with chronic treatment

Michele M Iester; Michele Figus; Paolo Fogagnolo; Paolo Frezzotti; Francesco Oddone; Antonio Ferreras

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4600.

ARVO Annual Meeting Abstract June 2017

Exploring the effects of an ophthalmic solution containing high concentration hyaluronic acid (0.4%) and taurine 0.5% on the ocular surface of glaucoma patients under topical hypotensive therapy

Francesca Berardo; Manuela Ferrazza; Gloria Roberti; Luca Agnifili; Lucia Tanga; Gianluca Manni; Michele Figus; Manuele Michelessi; Francesco Oddone

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5174.

ARVO Annual Meeting Abstract June 2013

Relationship between the macular ganglion cell complex thickness and standard automated perimetry in glaucoma

Antonio Ferreras; Blanca Monsalve; Pilar Calvo; Ana Pajarin; Paolo Frezzotti; Paolo Fogagnolo; Michele Figus; Michele Iester

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1902.

ARVO Annual Meeting Abstract June 2013

Efficacy, safety, and improved tolerability of preservative-free timolol 0.1% gel formulation compared with prior a BAK-preserved therapy

Paolo Frezzotti; Michele Figus; Carlo Cagini; Ilaria Motolese; Chiara Posarelli; Anna Bartolini; Simone Alex Bagaglia; Alessandra De Carolis; Eduardo Motolese

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):453.

ARVO Annual Meeting Abstract June 2013

Ocular Surface Changes in Glaucomatous Patients Treated with and without Preservatives beta-Blockers

Serena Telani; Michele Iester; Paolo Frezzotti; Michele Figus; Paolo Fogagnolo; Andrea Perdicchi; Antonio Ferreras; Carlo Enrico Traverso; beta-blocker study group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5427.

ARVO Annual Meeting Abstract June 2013

A twelve-months, randomized, prospective, open-label, parallel-group of in vivo confocal microscopic findings in glaucoma patients treated with bimatoprost 0.01% or bimatoprost 0.03%

Michele Figus; Stefano Lazzeri; Chiara Posarelli; Luca Martini; Marco Nardi

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):780.

ARVO Annual Meeting Abstract March 2012

Discriminating Between Healthy And Glaucomatous Eyes With Spectral-domain Optical Coherence Tomography

Antonio Ferreras; Blanca Monsalve; Pilar Calvo; Ana B. Pajarin; Laura Gil-Arribas; Michele Figus; Paolo Fogagnolo; Paolo Frezzotti; Luis E. Pablo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):660.

ARVO Annual Meeting Abstract April 2011

Agreement to Detect Glaucomatous Visual Field Progression by Using Statistical Analysis and Clinical Judgment

Cristiana Valente; Paolo Brusini; Paolo Capris; Guido Corallo; Michele Figus; Paolo Fogagnolo; Paolo Frezzotti; Gianluca Manni; Andrea Perdicchi; Michele M. Iester

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4158.

ARVO Annual Meeting Abstract April 2011

Blindness And Glaucoma: A Multicenter Data Review

Paolo Fogagnolo; Paolo Frezzotti; Antonio M. Fea; Michele Iester; Michele Figus; Antonio Ferreras; Teresa Rolle; Maurizio Digiuni; Valentina Battaglino; Luca M. Rossetti

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5052.

ARVO Annual Meeting Abstract April 2011

Diagnostic Ability Of Heidelberg Edge Perimetry For Glaucoma

Antonio Ferreras; Pilar Calvo; Ana B. Pajarin; Blanca Monsalve; Paolo Fogagnolo; Paolo Frezzotti; Michele Figus; Luis E. Pablo

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5524.

NARROW

Content Type

Journal

Article Type

Specify Date Range

Three-years effectiveness and safety of XEN45 implant: data from the Italian XEN Glaucoma Treatment Registry.

Proteomic analysis of Peripheral Blood Mononuclear Cells uncovers dysregulation of key pathways in primary open angle glaucoma subjects

Automatic Quantification of Major OCT Biomarkers in Diabetic Macular Edema: an AI Validated Approach

OCT Hyperreflective Retinal Foci as Sign of Microglial Activation in Diabetic Retinopathy: an AI Automatic Quantification Approach

Intraretinal and Subretinal Fluid in Diabetic Macular Edema: an AI Volumetric and Topographic Quantification Approach

The current clinical profile of patients eligible for glaucoma surgery and related type of intervention

Color-Code classification versus continuous data by Spectral Domain-Optical Coherence Tomography for detecting glaucoma: Multicenter Italian Glaucoma Imaging Study (MIGIS).

Effect of adherence to the Mediterranean diet on diabetic retinopathy and choroidal thickness

Diagnostic accuracy of optic disc, macular and retinal nerve fiber layer analysis by means of SD-OCT at different stages of the glaucoma disease: Multicentric Italian Glaucoma Imaging Study (MIGIS).

Artificial tear substitutes and ocular surface in glaucoma patients with chronic treatment

Exploring the effects of an ophthalmic solution containing high concentration hyaluronic acid (0.4%) and taurine 0.5% on the ocular surface of glaucoma patients under topical hypotensive therapy

Relationship between the macular ganglion cell complex thickness and standard automated perimetry in glaucoma

Efficacy, safety, and improved tolerability of preservative-free timolol 0.1% gel formulation compared with prior a BAK-preserved therapy

Ocular Surface Changes in Glaucomatous Patients Treated with and without Preservatives beta-Blockers

A twelve-months, randomized, prospective, open-label, parallel-group of in vivo confocal microscopic findings in glaucoma patients treated with bimatoprost 0.01% or bimatoprost 0.03%

Discriminating Between Healthy And Glaucomatous Eyes With Spectral-domain Optical Coherence Tomography

Agreement to Detect Glaucomatous Visual Field Progression by Using Statistical Analysis and Clinical Judgment

Blindness And Glaucoma: A Multicenter Data Review

Diagnostic Ability Of Heidelberg Edge Perimetry For Glaucoma

To View More...

You must be signed into an individual account to use this feature.